Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

Colin D. Godwin, MDMPhil, Yi Zhou, MD PhD, Megan Othus, PhD, Carole M. Shaw, BA, Kelda M. Gardner, PA-C, Brent L Wood, MD PhD, Roland B. Walter, MD PhD MS, Elihu H. Estey, MD

Blood (2019) 134 (Supplement_1): 2729.

https://doi.org/10.1182/blood-2019-127128

Published: 2019

Journal Articles

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Yi Zhou, MD, Megan Othus, PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD, David Wu, MD PhD, Brent Wood, MDPhD

Blood (2017) 130 (Supplement 1): 2701.

https://doi.org/10.1182/blood.V130.Suppl_1.2701.2701

Published: 2017

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Is It Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

Daisuke Araki, MD, Brent L Wood, MD PhD, Megan Othus, PhD, Jerald P. Radich, MD, Anna B. Halpern, MD, Yi Zhou, MD PhD, Marco Mielcarek, MD, Elihu H. Estey, MD, Frederick R. Appelbaum, MD, Roland B. Walter, MD PhD MS

Blood (2015) 126 (23): 2571.

https://doi.org/10.1182/blood.V126.23.2571.2571

Published: 2015

Journal Articles

Significance of Peri-Transplant Dynamics of Minimal Residual Disease (MRD) in Adults with Acute Myeloid Leukemia (AML) in Morphological Remission Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

Yi Zhou, MD PhD, Daisuke Araki, MD, Megan Othus, PhD, Jerald P. Radich, MD, Anna B. Halpern, MD, Marco Mielcarek, MD, Elihu H. Estey, MD, Brent L. Wood, MD PhD, Frederick R. Appelbaum, MD, Roland B. Walter, MD PhD MS

Blood (2015) 126 (23): 173.

https://doi.org/10.1182/blood.V126.23.173.173

Published: 2015

Journal Articles

Rituximab Maintenance Therapy after Autologous Stem Cell Transplantation Improves Survival of Patients with Mantle Cell Lymphoma

Solomon A. Graf, MD, Philip A. Stevenson, MS, Leona A. Holmberg, MD PhD, Brian G. Till, MD, Oliver W. Press, MD PhD, Thomas R. Chauncey, MD PhD, Stephen D. Smith, MD, Mary Philip, MD PhD, Johnnie J. Orozco, MD PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Edward N. Libby, MD, William I. Bensinger, MD, John M. Pagel, MD PhD, David G Maloney, MDPhD, Yi Zhou, MD PhD, Ryan D. Cassaday, MD, Ajay K. Gopal, MD

Blood (2014) 124 (21): 3985.

https://doi.org/10.1182/blood.V124.21.3985.3985

Published: 2014

Journal Articles

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

Xiao-hui Zhang, MD, PhD, Guo-xiang Wang, MD, Yan-rong Liu, MD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Wei Han, MD, Yu Wang, MD, Hai-xia Fu, MD, Meng Lv, MD, Min Wang, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3077.

https://doi.org/10.1182/blood.V120.21.3077.3077

Published: 2012

Journal Articles

All-Trance Retinoid Acid (ATRA) Makes Refractory Immune Thrombocytopenia (RITP) Less Refractory: A Retrospective Study of Ritp Patients Treated with Combination Therapies Including ATRA

Min Wang, MD, Xiao-hui Zhang, MD, PhD, Wei Han, MD, Yu Wang, MD, Dai-Hong Liu, MD, PhD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Hai-xia Fu, MD, Meng Lv, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3338.

https://doi.org/10.1182/blood.V120.21.3338.3338

Published: 2012

Journal Articles

Pre-Transplant Minimal Residual Disease Detected by Multiparameter Flow Cytometric Analysis Predicts for Disease Relapse in Adult Patients with Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell transplantation

Yi Zhou, MD, PhD, Jeffrey L. Jorgensen, MD, PhD, Rima M Saliba, PhD, Sa A. Wang, MD, Gabriela Rondon, MD, Celina Ledesma, B.S., Borje S Andersson, MD, PhD, Marcos J de Lima, MD, Elizabeth J Shpall, MD, Uday Popat, M.D., Stefan O Ciurea, MD, Amin M Alousi, MD, Muzaffar Qazilbash, MD, Chitra M Hosing, MD, L. Jeffrey Medeiros, MD, Richard Champlin, MD, Partow Kebriaei, MD

Blood (2011) 118 (21): 3072.

https://doi.org/10.1182/blood.V118.21.3072.3072

Published: 2011

NARROW

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Is It Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

Significance of Peri-Transplant Dynamics of Minimal Residual Disease (MRD) in Adults with Acute Myeloid Leukemia (AML) in Morphological Remission Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

Rituximab Maintenance Therapy after Autologous Stem Cell Transplantation Improves Survival of Patients with Mantle Cell Lymphoma

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

All-Trance Retinoid Acid (ATRA) Makes Refractory Immune Thrombocytopenia (RITP) Less Refractory: A Retrospective Study of Ritp Patients Treated with Combination Therapies Including ATRA

Pre-Transplant Minimal Residual Disease Detected by Multiparameter Flow Cytometric Analysis Predicts for Disease Relapse in Adult Patients with Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only